Data integrity – Page 29

Electronic Records Retention Strategy for GMP Systems

Developing an Effective Retention Strategy for Electronic Records in GMP Settings In the pharmaceutical industry, the management of electronic records and electronic signatures is critical for compliance and operational efficiency.…

How to Prevent Data Migration Validation in Backup, Archival & Data Retention

Strategies to Ensure Data Migration Validation for Backup, Archival and Retention Processes In the pharmaceutical manufacturing sector, managing data accurately and securely is paramount, particularly during data migration processes. Failure…

How to Control User Access in Electronic Records Systems

Controlling Access in Electronic Records Systems: Practical Solutions for Compliance Risks In the evolving landscape of pharmaceutical manufacturing and quality assurance, securing electronic records and electronic signatures (ERES) is paramount…

Step-by-Step Guide to Managing Cloud Backup Governance Under ALCOA+ Expectations

Managing Cloud Backup Governance to Meet ALCOA+ Standards In the highly regulated pharmaceutical industry, the integrity of data and records is paramount. As organizations increasingly utilize cloud solutions for data…

ERES Failures Found During Pharma Regulatory Inspections

Case Study: Investigating Failures in Electronic Records and Signatures during Pharma Inspections In the realm of pharmaceutical manufacturing, adherence to regulatory standards surrounding electronic records and electronic signatures (ERES) is…

Why Backup Frequency Justification Happens and How QA Teams Should Control It

Handling Backup Frequency Justifications: Effective Controls for QA Teams In the pharmaceutical industry, effective data management is crucial for compliance and operational efficiency. A common challenge faced by Quality Assurance…

Electronic Signature Meaning: Review, Approval, and Verification Controls

Understanding Electronic Signatures: Ensuring Compliance and Integrity in Pharma Operations In the pharmaceutical sector, the integrity of processes is paramount; however, the implementation of electronic records and electronic signatures (ERES)…

Inspection-Ready Approach to Electronic Record Retrieval Delays in Pharmaceutical Operations

Effective Strategies to Address Electronic Record Retrieval Delays in Pharma Operations In today’s fast-paced pharmaceutical environment, timely access to electronic records is crucial for operational efficiency and compliance. Delays in…

How to Design Audit Trails for Electronic Record Integrity

Creating Effective Audit Trails for Electronic Record Integrity The integrity of electronic records is a common concern in pharmaceutical manufacturing and quality assurance. As companies transition to digital solutions, the…

Raw Data Retention: Root Causes, GMP Risks, and CAPA Controls

Understanding Raw Data Retention: Addressing Root Causes and Implementing Effective CAPA Controls In the highly regulated pharmaceutical landscape, compliance with Good Manufacturing Practice (GMP) is non-negotiable, particularly concerning data integrity.…

EU Annex 11 and ERES: What Pharma Teams Must Control

Essential Control Strategies for Electronic Records and Electronic Signatures in Pharma The adoption of electronic records and electronic signatures (ERES) within pharmaceutical operations brings several advantages, such as improved efficiency…

How to Prevent Legacy System Decommissioning in Backup, Archival & Data Retention

Strategies to Mitigate Legacy System Decommissioning in Data Backup and Retention In the pharmaceutical industry, the reliance on legacy systems for backup, archival, and data retention practices is becoming increasingly…